Posted: 4/30/2013
|
Pharma IQ takes a closer look at the 30 pharmaceutical contract manufacturing innovators to watch in 2013.... Full Article » |
-
What is an ELN? by Michael Elliott Watch Now »
-
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem Watch Now »
-
Protecting your Pharma Intellectual Property during Out-Licensing Watch Now »
-
Drive Successful Commercial Product Launches through Effective Key Packaging Watch Now »
-
Follow Good Weighing Practice™ (GWP®), the Global Weighing Standard, and learn about Accurate Weighing in the Pharmaceutical Industry Watch Now »
- Labs in Transition: The Digital Face of Laboratory Science 5/21/2013
- DSM-5: Diagnosis Trouble 5/20/2013
- Intelligent Drug Development Applied to Drug Transporters 5/17/2013
- Top 10 Statistics From Pharma IQ's Clinical Trial Supply Survey 5/17/2013
- Angelina Jolie and the Maturity of Genomics 5/16/2013
- How High Level Information and Hypothesis-Driven Research can Accelerate Industrial Drug Design- Dr Simon Newstead 5/15/2013
DSM-5: Diagnosis Trouble
Contributor: Gerald ClarkePosted: 5/20/2013
|
The controversy surrounding the impending release of the DSM-5 may have spurred on one of the most interesting developments in psychiatric medicine in decades. Our editor investigates the controversy and asks what's next for the world's most influential diagnostic manual. Full Article » |
Turkish Pharmaceutical Track & Trace System: Understanding ITS Workflow
Contributor: ITS Turkish Pharmaceutical Track & Trace SystemPosted: 5/21/2013
ITS was the first successful and unique application of “Pharmaceutical Track and Trace System” in the world. ITS is designed to track the location of every drug unit to ensure the reliable supply of drugs to patients. Therefore, all the drugs on the market are traced by notifications in all phases from production to consumption. Thus; the sale of fraudulent drugs, drug theft and barcode scams are prevented. In addition, if required, drugs can easily be recalled due to traceability of stocks. Full Video » |
How High Level Information and Hypothesis-Driven Research can Accelerate Industrial Drug Design- Dr Simon Newstead
Contributor: Gerald ClarkePosted: 5/15/2013
|
Dr Simon Newstead explores why uptake transporters are important in drug development, the merits of a structure based analysis, the impact of the recent ITC recommendations and how they will impact research in the next 5 years. Full Podcast » |
Clinical Trial Supply USA: Investment & Opportunity
Posted: 5/22/2013This infographic reveals the latest thinking on clinical trial supply and where it is going. Find out more today! Full Whitepaper » |
-
Compound Management & Integrity - May 2013
May 21-23, 2013,
Thistle Marble Arch , London, United Kingdom -
4th Anti-Counterfeiting for Pharmaceuticals
May 22-24, 2013,
Renaissance Philadelphia Airport, Philadelphia, PA -
BioLogistics
June 3-5, 2013,
Golden Gateway Hotel, San Francisco, CA
|
|
The USP published new drafts to revise the General Chapters 41 “Balances” and 1251 “Weighing on an Analytical Balance” in the... |
Posted by: aholder | Answer this question
|
|
different tactics that you would use for product marketing strategies suck as pre launch, launch, post launch? |
Posted by: leiasantos34 | Answer this question
|
|
Is it possible with a MEG (Magnetoencephalography) to measure the neural activitu or the VLPO (neuron firings)? |
Posted by: Insomnia | Answer this question
|
|
what is the requirement of chewable tablet bioequivalance study for brazil and what are the general |
Posted by: ramesh89pharma | Answer this question
|
|
what is pre-planing for start the small scale pharmaceutical industries, documentation list of small scale pharmaceutical industries. |
Posted by: yogeshc786 | Answer this question
|
|
what is assay limit for analysis of process validation samples |
Posted by: pravin007 | Answer this question
Andrea Charles |
About Pharma IQ
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical and biotechnology professionals with knowledge, information and biotechnology articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical and biotech community.
|




















Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!